mariPOC® respiratory infection product line
Scientific literature (most important ones)
Monitoring of SARS-CoV-2 infection from nasopharyngeal swab, saliva, feces and urine by a quantitative rapid antigen test. Nuttens, J, et al. 37th Annual meeting of the Nordic Society of Clinical Microbiology and Infectious Diseases (NSCMID) 2021, Turku, Finland. Poster, abstract, and audio presentation #39.
Oseltamivir treatment of influenza A and B infections in infants. Mattila JM, et al.
Influenza and Other Respiratory Viruses. (2021) 15:618–624.
Prospective evaluation of a new mariPOC respi test with improved sensitivity for influenza A virus. Thomas E, et al. 28th European Congress of Clinical Microbiology and Infectious Diseases 2019, Amsterdam, the Netherlands. Abstract #2977 and poster #P0114.
Comparison of phenotypic and genotypic diagnosis of acute human bocavirus 1 infection in children. Kols NI, et al. J Clin Virol. (2019) 120:17–19.
Rapid detection and monitoring of human coronavirus infections. Bruning AH, et al. New Microbes New Infect. (2018) 24:52–55.
Development and validation of a new mariPOC influenza A virus test with enhanced sensitivity. Antikainen P, et al. 27th European Congress of Clinical Microbiology and Infectious Diseases 2017, Wien, Austria. Abstract #4575 and poster #P0910.
New QuickStrepA test of automated mariPOC® system provides culture sensitivity in 15 minutes. Antikainen P, et al. 34th annual meeting of NSCMID 2017, Tórshavn, Faroe Islands, Denmark. Poster and abstract # PP02.36.
Detection and monitoring of Human Bocavirus 1 infection by a new rapid antigen test. Bruning AH, et al. New Microbes New Infect. (2016) 11:17–19.
Analytical performance of the automated multianalyte point-of-care mariPOC® for the detection of respiratory viruses. Sanbonmatsu-Gámez S, et al. Diagn Microbiol Infect Dis. (2015) 83:252–256.
Detection of Group A Streptococcus from Pharyngeal Swab Samples by Bacterial Culture is Challenged by a Novel mariPOC Point-of-Care Test. Vakkila J, et al. J Clin Microbiol. (2015) 53:2079–2083.
Comprehensive real-time epidemiological data from respiratory infections in Finland between 2010 and 2014 obtained from an automated and multianalyte mariPOC® respiratory pathogen test. Gunell M, et al. Eur J Clin Microbiol Infect Dis. (2016) 35:405–13.
Evaluation of the Automated Multianalyte Point-of-Care mariPOC® Test for the Detection of Influenza A Virus and Respiratory Syncytial Virus. Tuuminen T, et al. J Med Virol. (2013) 85:1598–1601.
Identification of Respiratory Viruses with a Novel Point-of-Care Multianalyte Antigen Detection Test in Children with Acute Respiratory Tract Infection. Ivaska L, et al. J Clin Virol. (2013) 57:136–140.
Performance Evaluation of Multianalyte mariPOC® Respiratory Infection Test for Adenovirus Types 1-8, 14, 19 and 21. Koskinen JO, et al. 22nd European Congress of Clinical Microbiology and Infectious Diseases 2012, London, Great Britain. Abstract R2630.
Rapid Method for Detection of Influenza A and B Virus Antigens by Use of a Two-Photon Excitation Assay Technique and Dry-Chemistry Reagents. Koskinen JO, et al. J Clin Microbiol. (2007) 45(11):3581–3588.
Variation of coronavirus OC43 results in recurrent infections. Koskinen JM, et al. Virology Days 2018, Tuusula, Finland. Oral presentation and abstract # 9.
Automated mariPOC® platform enables highly sensitive and rapid antigen detection and subtyping of influenza viruses. Antikainen P, et al. International scientific WHO conference “Trends in influenza research” 2017, St. Petersburg, Russia. Oral presentation. Abstract O23, pages 71–73.
Diagnostic test gets a positive result (PPC Dec 2015)
Interview of Pentti Huovinen, dean of medicine, University of Turku, Finland: Rapid Detection of Strep A (PPC Nov 2015)
Respiratory infection management requires high specificity tests (PPC, Nov 2015)
A new diagnostic tool for process improvements (PPC, July 2015)
Time to set new standard in GAS testing (PPC, April 2015)